1. Home
  2. BOLT vs CLEU Comparison

BOLT vs CLEU Comparison

Compare BOLT & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • CLEU
  • Stock Information
  • Founded
  • BOLT 2015
  • CLEU 2011
  • Country
  • BOLT United States
  • CLEU China
  • Employees
  • BOLT N/A
  • CLEU N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • CLEU Other Consumer Services
  • Sector
  • BOLT Health Care
  • CLEU Real Estate
  • Exchange
  • BOLT Nasdaq
  • CLEU Nasdaq
  • Market Cap
  • BOLT 16.8M
  • CLEU 20.0M
  • IPO Year
  • BOLT 2021
  • CLEU 2020
  • Fundamental
  • Price
  • BOLT $0.40
  • CLEU $1.93
  • Analyst Decision
  • BOLT Hold
  • CLEU
  • Analyst Count
  • BOLT 5
  • CLEU 0
  • Target Price
  • BOLT $1.13
  • CLEU N/A
  • AVG Volume (30 Days)
  • BOLT 146.3K
  • CLEU 174.8K
  • Earning Date
  • BOLT 05-13-2025
  • CLEU 10-11-2024
  • Dividend Yield
  • BOLT N/A
  • CLEU N/A
  • EPS Growth
  • BOLT N/A
  • CLEU N/A
  • EPS
  • BOLT N/A
  • CLEU N/A
  • Revenue
  • BOLT $7,690,000.00
  • CLEU $2,413,409.00
  • Revenue This Year
  • BOLT N/A
  • CLEU N/A
  • Revenue Next Year
  • BOLT $77.45
  • CLEU N/A
  • P/E Ratio
  • BOLT N/A
  • CLEU N/A
  • Revenue Growth
  • BOLT N/A
  • CLEU N/A
  • 52 Week Low
  • BOLT $0.38
  • CLEU $0.05
  • 52 Week High
  • BOLT $1.48
  • CLEU $7.90
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 40.42
  • CLEU 50.10
  • Support Level
  • BOLT $0.38
  • CLEU $1.80
  • Resistance Level
  • BOLT $0.47
  • CLEU $2.24
  • Average True Range (ATR)
  • BOLT 0.04
  • CLEU 0.30
  • MACD
  • BOLT -0.00
  • CLEU -0.02
  • Stochastic Oscillator
  • BOLT 18.81
  • CLEU 14.61

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About CLEU China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.

Share on Social Networks: